FDA Approves Combo Eye Drop For Glaucoma | OphthalmologyWeb: The Ultimate Online Resource for Ophthalmologists

Wednesday, October 31, 2007

Email

Comments

Reuters

Regulators approved a new glaucoma treatment -- Combigan, an eye drop that treats the potentially blinding eye condition with two drugs that work through different mechanisms, Allergan Inc said Wednesday.

Glaucoma Testing Equipment / Glaucoma Products »

All of the following are true of primary Sjogren Syndrome except:
1. Most commonly found in elderly males
2. No associated connective tissue disease
3. 90% HLA-B8 haplotype +
4. Associated with anti-La (SS-B) autoantibodies
Check The Answer

CareCloud Charts For Ophthalmology
Get all of the tools you need to deliver... view product
Selecta Trio™ YAG Laser, SLT and Photocoagulation
The Lumenis Selecta® Trio™ ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us